Board of Directors
Meet our Board of Directors members
Christine M. Cournoyer
Christine M. Cournoyer became a director of Spok in March 2020 and was elected Chair of the Board in July 2022. She also serves as Chair of the Nominating and Governance Committee and as a member of the Audit Committee. Cournoyer currently serves as a strategic advisor to digital health companies and as a board member of CareDx, Inc., a leading precision medicine company providing solutions for transplant patients, since 2019. She served as CEO and Chairperson of N-of-One, Inc. from 2012 to 2019 until it was acquired by QIAGEN N.V., for whom she served as a strategic advisor for the remainder of 2019. In her time as CEO of N-of-One, Inc. Cournoyer led the transformation from a patient concierge business to a leading molecular decision support company selling to large health providers and leading molecular diagnostic commercial labs. She, along with the efforts of her team, created a HIPAA compliant platform running in the cloud that scaled to interpret hundreds of thousands of molecular diagnostics tests. From 2010 to 2011 Cournoyer served as the VP of Clinical Analytics for United-Health Group/Optum where she was responsible for clinical solutions and defining the clinical support strategy. Between 2006 and 2010 she was the President and COO for Picis, a global leader in healthcare IT. Cournoyer also served as a board member of Emerson Hospital from 2012 to 2018, BJ’s Wholesale Club from 2008 to 2011, Stride Rite from 2001 to 2007, and GTech from 2003 to 2006. Prior positions include Managing Director, Database Division, of Harte Hanks, and VP of Global Business Transformation and CIO of the IBM Software Group.
Cournoyer has over 30 years of management experience in the Software and Healthcare IT industry and has extensive public and private board experience, having served on the Board of Directors for three public companies: Stride Rite, GTECH, and BJ’s Wholesale Club. Cournoyer served as the Chair of the Board of Directors for N-of-One, a privately held venture backed company in molecular/genomics decision support. She is presently serving on the board of CareDx, a leader in the field of transplants. Cournoyer has experience serving on the Finance, Audit, and Compensation Committees, and has chaired a Technology Committee for two of the boards. Cournoyer has also served on a nonprofit board as a member of the Emerson Hospital Board of Trustees. She holds a B.S. degree in Business Administration from the University of Massachusetts, an M.A. in Economics from Northeastern University, and is a graduate of the MIT Executive Education Program.
Bobbie Byrne, MD, Chief Information Officer, Advocate Aurora Health
Bobbie Byrne, MD, became a director of Spok in January 2020. She is a member of the Compensation Committee, and of the Nominating and Governance Committee. Dr. Byrne has served as Chief Information Officer at Advocate Aurora Health since 2017 and is responsible for all information technology applications, information security, infrastructure, clinical informatics, data warehousing, and business intelligence across the entire healthcare system. In 2017 she served as CMO at Edward-Elmhurst Health where she was responsible for quality and safety, clinical research, information technology, and patient experience and prior to that she was the CIO from 2009 to 2017 where she oversaw the Epic and Lawson implementations. Dr. Byrne was the Clinical Director at the Certification Commission for Healthcare Information Technology in 2009 and served as the SVP, Clinical Solutions for Eclipsys, Inc. (now Allscripts, Inc.) from 2005 to 2009.
Randy Hyun, COO of CarepathRx LLC and CEO of CarepathRx Health Systems Solutions
Randy Hyun became a director of Spok in July 2021 and is Chair of the Compensation Committee. He also serves on the Audit Committee. Hyun has extensive management experience in the healthcare services industry spanning over 20 years and includes a robust background in strategy and operations. Hyun currently serves as the Chief Operating Officer of CarepathRx LLC and the Chief Executive Officer of CarepathRx Health Systems Solutions. At CarepathRX, a privately held company that provides technology-based pharmacy and technology solutions to hospitals, payers, and patients, Hyun is responsible for overseeing and managing the growth of the company and directly managing key corporate functions. Prior to joining Carepath Rx in 2020, Hyun was Chief Executive Officer of Aetna Medicaid from 2018 through 2020 and President of Aetna Pharmacy Management from 2017 to 2018, both subsidiaries of CVS Health, a provider of health services in the health insurance, PBM, and retail pharmacy markets. From 1997 until 2017, Hyun held varying roles of increasing responsibility at McKesson Corporation, a provider of supply chain and technology solutions to healthcare providers. Hyun received his M.B.A. from The Wharton School at the University of Pennsylvania and his B.S. in Mechanical Engineering from the Massachusetts Institute of Technology.
Vincent Kelly, President and CEO of Spok Holdings, Inc. formerly USA Mobility, Inc.
Vince Kelly has been a leader in the communications industry for more than 35 years with extensive experience in strategic planning, mergers and acquisitions, regulatory and financial matters. He became a director, president, and CEO of USA Mobility, Inc. (now Spok Holdings, Inc.) in November 2004 when the company was formed through the merger of Metrocall, Inc. and Arch Wireless, Inc. Prior to the merger, Kelly held various roles at Metrocall including serving as a member of the board of directors, chief executive officer, chief operating officer, chief financial officer, and executive vice president. In 2011, Kelly was instrumental in completing the acquisition of Amcom software, kicking off a rebrand and multi-year pivot for USA Mobility, now Spok, into an industry-leading clinical communications and collaboration solutions provider.
Kelly has served on multiple public company boards and has been a member of audit and special committees. Kelly currently serves as the president, CEO, and director for all of Spok’s subsidiaries, except for GTES, LLC, an indirect wholly owned Canadian subsidiary, for which he is a director.
Kelly has a Bachelor of Science in accounting from George Mason University. Prior to joining Metrocall in 1987, Kelly was a certified public accountant.
Brett Shockley, CEO and Chairman of Journey AI, Inc.
Brett Shockley became a director of Spok in June 2020. He is a member of the Nominating and Governance Committee, the Compensation Committee, and the Audit Committee. Shockley currently serves as the Chief Executive Officer and Chairman of Journey AI, Inc., a private software company that provides a trusted identity platform delivering security, privacy, and frictionless customer experience solutions to the contact center industry, since he co-founded the company in May 2016. He has also served on the Board of Directors of eGain Corporation (“eGain”), a software service provider, since January 2015 and has served as eGain’s Lead Independent Director since September 2017. From 2008 to 2014, Shockley held various positions at Avaya Holdings Corp., a technology company specializing in business communications, most recently serving as a Senior Vice President of Corporate Strategy, Corporate Development and Chief Technology Officer from May 2013 to December 2014. Prior to that, Shockley served as Chief Executive Officer, President and a Co-Founder of Spanlink Communications, Inc., a provider of contact center technologies and network infrastructure implementations, from 1988 to 2008. In addition, from 2007 to 2008, Shockley served as the Co-Founder and a director of Calabrio, Inc., a workforce optimization software company.
Todd Stein became a director of Spok in July 2018. He is Chair of the Audit Committee. Stein is Co-Investment Manager of Dallas-based Braeside Investments, LLC, the investment manager of private investment partnerships focusing on global small and micro-cap equities. Stein’s core competency is applying fundamental analysis to purchase undervalued securities. Prior to co-founding Braeside in 2004, Stein was a portfolio manager at Q Investments, L.P. During his tenure at Q Investments, L.P., Stein co-managed a merger arbitrage portfolio in addition to serving as the firm’s primary analyst on its short distressed/bankrupt equities portfolio. In 2002, Stein was appointed by the U.S. Trustee of the Northern District of Illinois to serve on the official creditors’ committee of United Airlines. Stein holds the Chartered Financial Analyst designation.